Responsiveness to Full-Dose Afatinib in a Patient With Lung Adenocarcinoma Harboring EGFR S768I and V769L Mutations-MedSci.cn

Responsiveness to Full-Dose Afatinib in a Patient With Lung Adenocarcinoma Harboring EGFR S768I and V769L Mutations

Zhang, H; Shao, YW; Xia, Y

Xia, Y (reprint author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China.